A review of published cases of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of acetaminophen

References

• Kim EJ, Lim H, Park SY, et al. Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pac Allergy 2014;4:68–72.
   PubMedGoogle Scholar
• Acetaminophen. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [cited 2020 Nov 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK548162/
   Google Scholar
• Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm 2014;71:11–23.
   PubMed Web of Science ®Google Scholar
• Maxwell EN, Johnson B, Cammilleri J, et al. Intravenous acetaminophen-induced hypotension: a review of the current literature. Ann Pharmacother 2019;53:1033–1041.
   PubMed Web of Science ®Google Scholar
• Owczarczyk-Saczonek A, Zdanowska N, Znajewska-Pander A, et al. Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy. J Dermatol Case Rep 2016;10:14–16.
   PubMed Web of Science ®Google Scholar
• Raucci U, Rossi R, Cas RD, et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. Plos ONE 2013;8:e68231.
   PubMed Web of Science ®Google Scholar
• Levi N, Bastuji-Garin S, Mockenhaupt M, et al. Medications as risk factors of stevens-johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 2009;123:e297–304.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns of rare but serious skin reactions with the pain reliever/fever reducer acetaminophen [Internet]. 2020. [cited 2020 Nov 14]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-skin-reactions-pain-relieverfever-reducer
   Google Scholar
• Mockenhaupt M. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg 2014;33:10–16.
   PubMed Web of Science ®Google Scholar
• Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, et al. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinic Rev Allerg Immunol 2018;54:147–176.
   PubMed Web of Science ®Google Scholar
• Oba U, Yamada H, Suenobu S, et al. Toxic epidermal necrolysis in a child 6 months post-hematopoietic stem cell transplantation. Pediatr Transplantation 2017;21:e12931.
   Web of Science ®Google Scholar
• Gabrielli S, Langlois A, Ben-Shoshan M. Prevalence of Hypersensitivity Reactions in Children Associated with Acetaminophen: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol 2018;176:106–114.
   PubMed Web of Science ®Google Scholar
• McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol 2018;84:2218–2230.
   PubMed Web of Science ®Google Scholar
• Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Drug Saf 2007;30:367–373.
   PubMed Web of Science ®Google Scholar
• Biswal S, Sahoo SS. Paracetamol induced Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome. Int J Dermatol 2014;53:1042–1044.
   PubMed Web of Science ®Google Scholar
• Khawaja A, Shahab A, Hussain SA. Acetaminophen induced Steven Johnson Syndrome-Toxic Epidermal Necrolysis overlap. J Pak Med Assoc 2012;62:524–527.
   PubMed Web of Science ®Google Scholar
• Goto T, Yamashiro A, Maruyama N, et al. Acetaminophen-induced atypical Stevens-Johnson syndrome in a patient with acute oral bacterial infection: A case report and literature review. Oral Sci Int 2020;17:169–173.
   Web of Science ®Google Scholar
• Krajewski A, Mazurek MJ, Młyńska‐Krajewska E. Successful therapy of recurrent toxic epidermal necrolysis using total plasma exchange, continuous venovenous hemodiafiltration, and intravenous immunoglobulin-Case report. Dermatol Ther 2020;33:e13442.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Watanabe Y, Takamura N, et al. A case of toxic epidermal necrolysis with refractory acute respiratory distress syndrome. J Cutan Immunol Allergy 2020;3:43–44.
   Google Scholar
• Purkayastha A, Chakravarty P, Dewan B. A Case Report of Paracetamol-Induced Toxic Epidermal Necrolysis in a Female Patient at a Tertiary Care Hospital in Assam. Asian J Pharm Clin Res 2016;9:7–8.
   Google Scholar
• Watanabe H, Kamiyama T, Sasaki S, et al. Toxic epidermal necrolysis caused by acetaminophen featuring almost 100% skin detachment: Acetaminophen is associated with a risk of severe cutaneous adverse reactions. J Dermatol 2016;43:321–324.
   PubMed Web of Science ®Google Scholar
• Harimoto N, Wang H, Ikegami T, et al. Education and imaging. Hepatology: Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation . J Gastroenterol Hepatol 2015;30:656.
   PubMed Web of Science ®Google Scholar
• Rajput R, Sagari S, Durgavanshi A, et al. Paracetamol induced Steven-Johnson syndrome: A rare case report. Contemp Clin Dent 2015;6:S278–S281.
   PubMedGoogle Scholar
• Bouziri A, Khaldi A, Hamdi A, et al. Toxic epidermal necrolysis complicated by small bowel intussusception: a case report. J Pediatr Surg 2011;46:e9–e11.
   PubMed Web of Science ®Google Scholar
• Trujillo C, Gago C, Ramos S. Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient. Allergol Immunopathol (Madr) 2010;38:99–100.
   PubMed Web of Science ®Google Scholar
• Bygum A, Gregersen JW, Buus SK. Acetaminophen-Induced Toxic Epidermal Necrolysis in a Child. Pediatr Dermatol 2004;21:236–238.
   PubMed Web of Science ®Google Scholar
• Halevi A, Ben-Amitai D, Garty BZ. Toxic Epidermal Necrolysis Associated with Acetaminophen Ingestion. Ann Pharmacother 2000;34:32–34.
   PubMed Web of Science ®Google Scholar
• Khare KC, Khare S, Mathew G. Stevens Johnson syndrome with keratitis following paracetamol injection. Indian J Dermatol Venereol Leprol 1997;63:209.
   PubMedGoogle Scholar
• Szepietowski J, Wa̧Sik F, Szybejko-Machaj G, et al. Toxic epidermal necrolysis successfully treated with cyclosporin. Report of three cases. J Eur Acad Dermatol Venereol 1997;9:169–172.
   Web of Science ®Google Scholar
• Pena MÁ, Pérez S, Zazo MC, et al. A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child. Curr Drug Saf 2016;11:99–101.
   PubMed Web of Science ®Google Scholar
• St. John J, Ratushny V, Liu KJ, et al. Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children. Pediatr Dermatol 2017;34:540–546.
   PubMed Web of Science ®Google Scholar
• Hachimi A, Ziadi A, Khamlij A, et al. Un cas rare de toxidermie induite par le paracétamol: syndrome de Lyell [A rare case of paracetamol-induced skin toxicity: Lyell syndrome. Toxicol Anal Clin 2014;26:208–209.
   Google Scholar
• Takeuchi Y, Katagiri K, Hatano Y, et al. A Case of Toxic Epidermal Necrolysis due to Acetaminophen. Nishinihon J Dermatol 2004;66:385–388.
   Google Scholar
• Köksal BT, Özbek ÖY, Özmen E, et al. A pediatric case with the diagnosis of stevens johnson syndrome [Stevens Johnson Sendromu Tanısı Alan Bir Çocuk Olgu]. Guncel Pediatri 2018;16:115–124.
   Web of Science ®Google Scholar
• Ban GY, Ahn SJ, Yoo HS, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with acetaminophen use during viral infections. Immune Netw 2016;16:256–260.
   PubMed Web of Science ®Google Scholar
• Ioannides D, Vakali G, Chrysomallis F, et al. Toxic epidermal necrolysis: a study of 22 cases. J Eur Acad Dermatol Venerol 1994;3:266–275.
   Google Scholar
• Reese D, Henning JS, Rockers K, et al. Cyclosporine for SJS/TEN: a case series and review of the literature. Cutis 2011;87:24–29.
   PubMed Web of Science ®Google Scholar
• Gerdts B, Vloemans A, Kreis RW. Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre. J Eur Acad Dermatol Venereol 2007;21:781–788.
   PubMed Web of Science ®Google Scholar
• Laguna C, Martín B, Torrijos A, et al. Síndrome de Stevens-Johnson y necrólisis epidérmica tóxica: experiencia clínica y revisión de la literatura especializada. Actas Dermo-Sifiliográficas 2006;97:177–185.
   PubMedGoogle Scholar
• Dragojevic-Simic V, Vukovic J, Kovacevic A, et al. TP54 Paracetamol-induced toxic epidermal necrolysis in adult: clinical pharmacology unit case report. Basic Clin Pharmacol Toxicol 2009;105:98.
   PubMed Web of Science ®Google Scholar
• Zentiva. Paracetamol 500mg Tablets – Summary of Product Characteristics (SmPC) - (emc) [Internet]. 2020. [cited 2020 Nov 29]. Available from: https://www.medicines.org.uk/emc/product/5164/smpc
   Google Scholar
• Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010;5:39.
   PubMed Web of Science ®Google Scholar
• Ueta M, Nakamura R, Saito Y, et al. Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals. Hum Genome Var 2019;6:50.
   PubMed Web of Science ®Google Scholar
• Ueta M, Kaniwa N, Sotozono C, et al. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci Rep 2014;4:4862.
   PubMed Web of Science ®Google Scholar
• Jongkhajornpong P, Ueta M, Lekhanont K, et al. Association of HLA polymorphisms and acetaminophen-related Steven-Johnson syndrome with severe ocular complications in Thai population. Br J Ophthalmol 2020. Available from: https://bjo.bmj.com/content/early/2020/11/22/bjophthalmol-2020-317315.citation-tools
   PubMed Web of Science ®Google Scholar
• Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35–44.
   PubMed Web of Science ®Google Scholar
• Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, et al. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001;15:1843–1848.
   PubMed Web of Science ®Google Scholar
• Pejčić AV. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases. Int J Dermatol 2021;60:12–24.
   PubMed Web of Science ®Google Scholar
• Rashid M, Kashyap A, Undela K. Valproic acid and Stevens-Johnson syndrome: a systematic review of descriptive studies. Int J Dermatol 2019;58:1014–1022.
   PubMed Web of Science ®Google Scholar
• Devi K, George S, Criton S, et al. Carbamazepine-the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years. Indian J Dermatol Venereol Leprol 2005;71:325–328.
   PubMedGoogle Scholar
• Creamer D, Walsh SA, Dziewulski P, et al. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016 . Br J Dermatol 2016;174:1194–1227.
   PubMed Web of Science ®Google Scholar
• Rutkowski K, Nasser SM, Ewan PW. Paracetamol Hypersensitivity: Clinical Features, Mechanism and Role of Specific IgE. Int Arch Allergy Immunol 2012;159:60–64.
   PubMed Web of Science ®Google Scholar